Spyre Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Spyre Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Spyre Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2024 was -39.4K %, a 480% decline year-over-year.
  • Spyre Therapeutics, Inc. annual Operating Margin for 2023 was -27.3K %, a 651% decline from 2022.
  • Spyre Therapeutics, Inc. annual Operating Margin for 2022 was -3.64K %, a 939% decline from 2021.
  • Spyre Therapeutics, Inc. annual Operating Margin for 2021 was -350 %.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -27.3K -23.7K -651% Jan 1, 2023 Dec 31, 2023
2022 -3.64K -3.29K -939% Jan 1, 2022 Dec 31, 2022
2021 -350 Jan 1, 2021 Dec 31, 2021
2018 -1.17K -638 -120% Jan 1, 2018 Dec 31, 2018
2017 -532 -58.4 -12.3% Jan 1, 2017 Dec 31, 2017
2016 -473 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.